The integrity of the genome is under constant assault through errors in replication and chromosome mechanics, and through the action of extrinsic mutagens. Prokaryotic and eukaryotic cells have evolved a network of mechanisms for minimizing the consequences of DNA damage. Basal and damage-inducible DNA repair systems are called into play by an array of DNA lesions. Damage-regulated checkpoint controls are important elements of the cellular response to DNA lesions and presumably work by providing enough time for the operation of DNA repair systems. In parallel, replication-sensitive checkpoint controls may be important to ensure that cells remain in S until replication is complete. Failure of these cell cycle restraints can increase mutation rates and genomic instability, which can lead to cancer in humans (Hartwell and Kastan 1994}. p53, the most frequently mutated tumor suppressor gene, is required for damage-regulated arrest at the G1/S checkpoint (Lane 1992) . A second human checkpoint gene, ATM, is also a tumor suppressor gene. ATM mu4Corresponding author.
tations cause the ataxia telangiectasia {AT) syndrome, which is characterized by a number of defects including greatly elevated cancer risk (for review, see Meyn 1995) . Cells from AT individuals are hypersensitive to ionizing radiation and fail to show normal damage-induced cell cycle arrest. The A TM gene seems to operate upstream from p53 and is homologous to a gene family including lipid and protein kinases (Kastan et al. 1992; Lehmann and Cart 1995; Savitsky et al. 1995) . Significantly, ATM is structurally homologous to budding yeast TELI and MEC1, and fission yeast tad3+ (Kato and Ogawa 1994; Greenwell et al. 1995; Savitsky et al. 1995; Zakian 19951 . The latter two have DNA checkpoint functions, indicating a functional homology. Hence, the identification of the human damage checkpoint gene ATM forged a link with the genetic analysis of checkpoint control pathways in yeasts.
Multiple DNA-related checkpoint pathways have been identified in Saccharomyces cerevisiae. When DNA is damaged, these controls prevent cells in G~ from entering S phase, cells in late S or G~ phase from undergoing mitosis, and they also retard S phase progression (Weinert and Hartwell 1988; Hartwell and Weinert 1989; Siede et al. 1993; Paulovich and Hartwell 1995) . Another checkpoint prevents cells with incompletely replicated DNA from exiting S phase (Hartwell and Weinert 1989; Murray 1999.) . Three distinct sets of DNA checkpoint genes have been identified in S. cerevisiae. One set, including MEC3, RAD9, and RAD24, is required for function of the damage-regulated G1/S and late S/G2 checkpoints, and is dispensable for the S-phase replication checkpoint (Siede et al. 1993; Weinert et al. 1994) . A second set, defined by dun alleles of POL2, is required for the S-phase checkpoint but is unnecessary for the damage checkpoints (Navas et al. 1995) . Finally, the two essential genes MEC1 and SPKI/RAD53/SAD1/MEC2 are necessary for both damage-regulated and replication checkpoints (Allen et al. 1994; Weinert et al. 1994) . SPK1 encodes a protein kinase that is located primarily in the nucleus (Stem et al. 1991; Zheng et al. 1993) . SPK1 is activated transcriptionally near the G~/S boundary. This regulation is probably conferred by a pair of consensus Mlul cell cycle box IMCB) regulatory elements such as those found in a number of genes transcribed in S phase including DNA synthetic enzymes and cyclins Clb5 and Clb6. Other upstream sequences similar to DNA damage response elements suggested that SPKI is involved in the DNA damage response (Zheng et al. 1993) . SPK1, like MEC1, is required for the activation of DNA damage-induced checkpoints in G I and G2 and for the induction of the S phase checkpoint, as partial loss-of-function mutants are defective in these processes [Allen et al. 1994; Weinert et al. 1994) . In addition, SPKI is required for the transcriptional stimulation of DNA repair genes RNR2 and RNR3 (Allen et al. 1994) . This is genetically distinguishable from the checkpoint response, as dun l cells are checkpoint competent (Zhou and Elledge 1993) . Finally, the nuclear localization, transcriptional regulation, and terminal arrest phenotypes of spklA null mutants raised the possibility that the essential function of Spklp is associated with DNA replication {Zheng et al. 1993) . Hence, Spklp may be a pleiotropic regulator of both DNA replication and the damage response.
The distinct phenotypes of RAD9-1ike genes and POL2 (dun2)-like genes has led to the model that each set defines an independent signaling pathway activated by either DNA damage or partly replicated DNA. The common phenotypes of spkl and mecl and the fact that they are required for both sets of checkpoints might mean that these genes are involved in both sets of recognition processes or, alternatively, that they function in a common pathway downstream from the recognition pathways and couple those pathways to cell cycle arrest (Allen et al. 1994; Weinert et al. 1994} . Although these models are consistent with current data, there is virtually no direct evidence to verify them. For the most part, the existence of these pathways has been inferred from common mutant phenotypes, rather than genetic or biochemical epistasis experiments. For example, there is no direct evidence that Spklp and Meclp act in the same pathway or that either is regulated by DNA replication or DNA damage.
As a first step toward biochemically defining these checkpoint pathways, we have investigated the regulation of Spklp in the cell cycle and in response to induction of checkpoint arrest. We show here that Spklp phosphorylation is regulated by damage and replication checkpoints. Activation of Spklp through overexpression is sufficient to inhibit cell cycle progression at the G1/S boundary. The results suggest that Meclp and Spklp participate serially in a linear damage-and replication-regulated pathway in which Spklp is regulated in a protein kinase cascade.
Results

Cell cycle regulation of Spklp abundance an d modifica tion
Initially, SPKt transcripts are very low in G 1 arrested cells and increase to maximal levels as ceils enter S phase (Zheng et al. 1993 ). This apparent cell cycle regulation may be misleading, however, as the majority of MCB gene products give rise to stable proteins that do not fluctuate much during the cell cycle (McIntosh 1993) . Therefore, we examined Spklp abundance in a population of cells synchronized at Start and then released into G1 (Fig. 1 ) . Growth of strain 1608-21C (clnl/L cln2A, cln3A, GAL1-CLN31 (Table l J is strictly regulated by galactose induction of Cln3p. These cells arrest uniformly at Start in raffinose and proceed synchronously through the cell cycle after induction with galactose. Spk lp was present at Start and increased substantially 30 min after release from Start arrest, coincident with the emergence of small budded cells (Fig. 1A) . Spklp levels were sustained until 70 min, when large budded cells first appear [ Fig. 1AI . This timing is consistent with an S phase-specific increase in Spklp levels and is consonant with RNA analysis (Zheng et al. 1993) . In contrast to the mRNA, however, Spklp was present in significant quantities at Start, suggesting that Spklp is more stable than SPK1 mRNA.
In subsequent experiments with a different antibody preparation and different electrophoresis conditions, Spklp resolved into multiple species (Fig. 1B) . A lower mobility form appeared in parallel with small budded cells. [The sample for the 40 min time point was evidently lost, as Spklp persisted and remained shifted in other experiments (Fig. 1C ).] After 60 rain Spklp reverted to the lower molecular weight singlet form in parallel with the appearance of large budded cells (Fig.  1B) . Spklp remained in singlet form as cells divided and entered the next G1 (data not shown). Because cell cycle progression driven by CLN3 overexpression in a triple cln disruption background may be abnormal, we carried out similar experiments in which isogenic wild-type cells (1255-5C) were synchronized with a-factor. Under these conditions, the Spklp mobility shift was not detected (data not shown). This negative result may have resulted from poorer synchrony or may mean that the hanced by using an atypical Cln3-driven cell cycle. A number of functional differences have been described between Cln3 and Clnl and Cln2, although they are functionally redundant in passage through Start {Vallen and Cross 1995}.
Modification of Spklp in cell cycle-arrested cdc t-~ mutants
We then used a set of temperature-sensitive cell division cycle (cdctS I mutant strains under nonpermissive conditions to define more precisely the timing of the mobility shift. At 37°C, cdc28 (cyclin-dependent kinase] cells arrest at Start, whereas cdc34, cdc4, and cdc7 strains arrest after Start but before the onset of DNA synthesis {Here-ford and Hartwell 1974; Kohnan et al. 1992; Smith et al. 1992; Sorger and Murray 1992) . Cdc34p is a ubiquitinconjugating enzyme apparently required to activate G t / S Clb/Cdc28 complexes through destruction of the inhibitor Siclp [Schwob et al. 1994] . CDC4 interacts genetically with CDC34 (Smith et al. 1992) . Cdc7 is a protein kinase with a terminal arrest point genetically downstream of the cdc4 arrest point (Hereford and Hartwell 1974; Bahman et al. 1988] . Spklp migrated as a singlet in cdc28-, cdc34-, and cdc4-arrested cells but was shifted partially in cdc7-arrested cells {Fig. 2, lanes 01. Thus, Spklp begins to undergo modification near the GI/S boundary. We then examined Spklp in cells arrested in S phase.
cdc2 IDNA polymerase 8}; cdct 7 {DNA polymerase a), and cdc8 {thymidylate kinasel strains arrest with stalled DNA replication (Sclafani and Fangman 1984; Lucchini et al. 1990; Budd and Campbell 1993} . Consistent with results derived from the GAL-CLN3 arrest-release experiment {see Fig. 1B (Fig. 2, lane 0) . Spklp migrated as a singlet in all other M phase-arrested cdc m u t a n t s (Fig. 2, cdc20, cdcl4, cdc5 , cdclS, lanes 0).
Phosphatase treatment of Spklp
To determine w h e t h e r the mobility shift of Spklp results from phosphorylation, Spklp was immunoprecipitared from lysates of cdc8 ~ cells arrested at the nonpermissive temperature and incubated with calf intestine alkaline phosphatase (CIP}. Much of Spklp was converted to the basal mobility form (Fig. 5 , cf. 20-rain time point to G a l -S p k l basal forml. This conversion did not occur in the presence of f~glycerophosphate, a phosphatase inhibitor {Fig. 5). The remainder was converted to an intermediate form. Although it is likely that this component is partially CIP resistant for technical reasons {e.g., the precipitating antibody m a y block access to phosphorylation sites), it is possible that there is an additional modification (e.g., ubiquitination). strains, h4clal, hTc4al, h2c2al, h8clal, hl 7clal, and h16clal {cdc4, cdc7, cdc2, cdc8, cdcl7 , and cdcI6, respectively) strains as indicated were arrested by incubation at the nonpermissive temperature for 4 hr. Lysates were immunoprecipitated and immunoblotted with anti-Spklp.
Trans-phosphorylation of Spk lp
The regulated phosphorylation of Spklp could arise from autophosphorylation or from phosphorylation by another protein kinase. To distinguish between these two possibilities, Spklp phosphorylation was analyzed in (Fig. 6 , lanes H). Thus, HU induces Spklp phosphorylation in trans.
DNA dam age in duces Spk lp ph osph oryta tion in a cell cycle-independent manner
Spklp is postulated to be an intermediary in a signal transduction cascade linking incompletely replicated or damaged DNA to cell cycle arrest (Zhou and Elledge 1993; Allen et al. 1994) . If so, then induction of checkpoint arrest should activate Spklp functionally. Hence, we sought to determine whether Spklp is regulated by phosphorylation during the damage response. After treatment of log-phase cultures with the alkylating agent methyl methanesulfonate (MMSI, Spklp shifted to the low mobility form (see Fig. 2 ). There are at least two possible explanations for this result. One is that treatment with MMS leads to the accumulation of cells in cell cycle phases wherein Spklp is normally phosphorylated. An alternative is that exposure to MMS induces Spktp phosphorylation independently, through pathways associated with the DNA damage response. To distinguish between these two possibilities, cdc ts strains, prearrested in either G1 or M phases by temperature shift, were exposed to MMS or HU. Similarly, 1608-21C cells (clnlA, cln2A, cln3A, GAL-CLN3) were prearrested in G 1 by switching to glucose medium before treatment with MMS or HU. As discussed above, Spklp migrated either as a single band in untreated cells (1608-21C, cdc28, cdc34, cdc4, cdc20, cdcl4, cdc5 , and cdcl51 or was shifted partially (cdc7) (see Fig. 2 , lanes 0}. When these strains were treated with MMS, SpkIp was converted to the shifted form (see Fig. 2 , lanes M). This result demonstrates that the induction of Spklp phosphorylation in response to DNA damage is independent of position within the cell cycle and that none of these CDC and CLN genes are required for the induction of Spk 1 p phosphorylation. In contrast to MMS, HU did not affect Spklp mobility in G1 and M phase-arrested cells [see Fig. 2 , lanes H). This result is not surprising, as the effects of HU, which depletes nucleotide precursors, may only be sensed in the face of ongoing replication.
Some checkpoin t-defective mutants are defective in the induction of Spklp phosphorytation
The above results suggest a direct correlation between Spklp phosphorylation and the activation of checkpoint pathways. If Spklp phosphorylation is required for these pathways, it should be possible to identify checkpoint mutants that act upstream of Spklp by measuring the extent of Spk lp phosphorylation in checkpoint-defective strains treated with agents that induce checkpoint arrest (MMS and HUt. MEC1, MEC2/SPK1, and MEC3 were identified in a screen for mutants in the DNA damage checkpoint that is synthetically lethal with cdcl3 ts (Weinert et al. 1994) . MECI is related to human ATM (Savitsky et al. 19951 , and MEC2 is allelic to SPKI. MEC1 and MEC2 are both essential genes that are necessary for DNA damage-induced and S phase checkpoint pathways, whereas MEC3 is involved exclusively in DNA damageinduced checkpoint arrest (Weinert et al. 1994) . cdcl 7 t~ and cdcl 3 ~ were used to activate replication and damage checkpoints, respectively, in MEG +, mecl, mec2, and mec3 backgrounds [see Spklp was converted to the phosphorylated form after temperature shift in cdcl3 ~ MEC and cdcl 7 ~ MEC cells (Fig. 4A , lanes cdcl3/+ and cdcl7/+). In contrast, Spklp remained unshifted in cdcl3 t~ meet and cdcl 7 t* mecl strains (Fig. 4A, lanes cdcl3/1 and cdcI7/1] . Mobility shift of Spklp was observed in cdcl 7 mec3 cells but not in cdcl 3 mec3 cells.
To verify that the MEC-l-dependent shift of Spklp is not a result of cell cycle synchronization, we prearrested cells in M phase with nocodazole and then treated them with MMS (Fig. 4B) . In nocodazole-arrested wild-type cells, Spklp shifted in response to MMS, whereas in mecl-and mec3-arrested cells, Spklp remained at the unshifted position [Fig. 4B ). These results placed Meclp upstream from Spklp in both damage-and replicationregulated pathways, and Mec3p upstream from Spklp in the damage-regulated pathway where Mec3p functions.
Mec2-1p accumulated at low levels and remained at the singlet position in both cdcl3 t~ mec2 and cdcl7 ts mec2 cells at the nonpermissive temperature (Fig. 4A , lane cdcl 7/2 {for cdcl3, Z. Sun, unpubl.] and in nocodazole-arrested cells treated with MMS ( Fig. 4B} . Hence, the mec2-t defect may prevent interaction with upstream regulators. Both the failure of Mec2-1p to undergo phosphorylation in response to either DNA damage or DNA replication blocks and the low protein levels may account for the checkpoint defect of mec2-1 strains.
Kinase activity of Spklp increases with phosphorylation
The results described above demonstrate that Spklp phosphorylation is regulated during cell cycle progression and in response to DNA damage or blocks to DNA replication, and suggest that this phosphorylation links upstream regulation of damage-response pathways to Spklp. If this phosphorylation is significant, it would be expected to regulate Spk 1 p function. Therefore, we compared the kinase activities of shifted and basal forms of Spklp. We used an exogenous substrate (histone HI] in immune complex kinase assays to eliminate uncertainties regarding basal occupancy of Spklp autophosphorylation sites. GAL1-SPKl-overexpressed Spklp was immunoprecipitated from cells treated with HU, and immune complexes were incubated with [~/-32p]ATP and histone HI. The intensities of histone phosphorylation relative to Spklp levels {determined by immunoblotting] were normalized after quantification by PhosphorImager analysis. A representative experiment is shown in Figure  7 . Histone H1 kinase activity was not associated with the kinase-impaired mutant Spkl-lp (Fig. 7) , verifying that the assay measures Spklp activity and not that of a contaminating H1 kinase. (H1 kinase activity was not recovered with immune complexes from HU-treated spkl-1 cells either; data not shown.)In data from seven independent trials, the H1 kinase activity of Spklp from HU-treated cells normalized to Spklp protein level was 2.4 times that of unshifted Spklp (standard error = 0.5 ]. A two-tail t-test verified that this difference is statistically significant (P<0.05). Thus, Spklp catalytic activity is in- creased modestly after exposure of Spklp to agents that induce checkpoint arrest.
Overexpression of Spklp leads to cell cycle delay
If Spklp is a member of a pathway connecting DNA damage to checkpoint arrest, then functional activation of Spklp should be sufficient to induce arrest. To test this possibility, ceils carrying galactose-inducible SPK1 and checkpoint-defective spkl kinase mutants (Zheng et al. 1993; D.S. Fay and D.F. Stern, in prep.) Strains were grown in 2% raffinose and synchronized by cx-factor treatment as described previously tPizzagalli et al. 19921. Cells were grown to early log phase, and the medium was adjusted to 10 mM sodium citrate (pH 4), 200 ~g/ml bovine serum albumin, and 2 ~g/ml a-factor (Sigma). a-Factor was removed from the culture by filtration and washing when the proportion of unbudded eclls was -95%. At the time of ~-factor release, 2% galactose was added. FACS was performed as described previously (Foiani et al. 1994) . At the time of ~-facror release, 2% galactose was added. Fixation, propidium-iodide staining, and flow microfluorimetry analysis were performed as previously described (Foiani et at. 1995) . CA) Percentage budded cells as a function of time after mating factor release. {B-E) Flow analysis of log-phase cells and mating factor-synchronized cells as a function of time after mating factor washout.
0 log E pNB 187-spkl-K227A time (min) 5 log and budding until 90 rain (Fig. 8, GAL1 -SPK1 I. Thus, Spklp overexpression delays the G~/S transition (or prevents substantial replication from occurring within S). The inability of checkpoint-defective mutants to induce the delay suggests that overexpressed Spklp acts directly on checkpoint-specific targets.
Discussion
Spktp is a common signal transducer in muhiple checkpoint pathways
Previous evidence suggested that Spklp is a node for integration and transmission of the damage and replication checkpoint signals. This model predicts that [1] Spklp is required for these pathways; (2) intrinsic and extrinsic activation of these pathways should regulate Spklp; (3] Spklp regulation should be associated with altered Spklp function; and (4) artificial activation of Spklp should induce checkpoint arrest. With the present data, these criteria have now been met: (1) spkl mutants are checkpoint defective; {21 Spklp phosphorylation is increased by inducers of damage and replication checkpoints; (3) Spklp phosphorylation correlates with increased kinase activity; and (4) overexpression of Spklp, but not a checkpoint mutant, induces cell cycle delay.
Checkpoint regulation of Spklp
Spklp was mobility-shifted in cdc9 and cdcl3 cells, MMS-treated, and HU-treatcd cells. Thus, conditions that activate DNA damage-dependent checkpoint pathways, as well as the S phase (HU) checkpoint pathway, also up-regulate Spklp phosphorylation. Phosphorylation of Spklp after treatment with HU moderately increased the in vitro kinase activity of Spklp. Use of a more physiological substrate (once identified) or soluble enzyme rather than immune complexes might reveal a more profound catalytic regulation. Although it is possible that other phosphorylation-regulated processes (localization, stability, or binding to other proteins] are important for checkpoint functions, our finding that a kinose domain mutation that weakens, but does not ablate, Spklp catalytic activity leads to checkpoint defects suggests that catalytic regulation of Spk lp is a limiting component of Spklp signaling (D.S. Fay and D.F. Stern, in prep.).
MEC1 and MEC3 may act upstream of SPK1
In an effort to define further the signaling cascade leading to checkpoint activation, we examined cells containing checkpoint-defective alleles of MEC1 and MEC3 for the ability to shift Spklp in response to DNA damage and blocks to DNA replication. Spklp remained in the basally phosphorylated state after temperature shift of both m ec l cdc t 3 ~ and mec3cdc l 3 t~ cells and MM$ treatment of nocodazole-arrested mecI and mec3 cells. These results suggest that MECt and MEC3 lie upstream in the pathway leading to checkpoint arrest after DNA damage (Fig. 9}. It should Hari et al. 1995; Morrow et al. 1995; Savitsky et al. 1995 
DNA replication and checkpoint controls
In contrast to other checkpoint control genes, Mec 1 p and Spklp share the property of being essential for viability.
Little is known about the essential functions of these proteins, but based on circumstantial evidence {coregu-lation with DNA synthetic enzymes, terminal arrest phenotype, nuclear localizationl we have hypothesized that the essential function of Spklp is associated with DNA replication (Zheng et al. 1993 
Materials and methods
Immunoprecipitation of Spklp
Immunoprecipitations were carried out in antibody excess as determined by titration. For Figures 1A and B, 2, 3, 4B and C, 5, and 6, cells from 500 ml of culture per sample were collected by centrifugation and suspended in 2 ml of glass bead disruption buffer [20 mM Tris-HC1 (pH 7.9), 10 mM MgC12, 1 mM EDTA, 5% glycerol, 0.3 M ammonium sulfate, with freshly added 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, lx protease inhibitor mix {Ausubet et at. 1991}, 1 mM sodium orthovanadate, and 100 ~M sodium orthovanadate]. Samples were vortexed five times for 45 sec in the presence of glass beads interspersed with cooling on ice for 1-2 min. Two milliliters of TG--VO 4 solution I1% Triton X-100, 10% glycerol, 0.198 trypsin inhibitor units {TIU] of aprotinin per milliliter of Dulbecco's phosphate-buffered saline lacking divalent cations with fresh 100 gM sodium orthovanadate] was added, and samples were vortexed for an additional minute. Samples were cleared by centrifugation at 2500 rpm for 10 rain at 4°C in an IEC DPR-6000 centrifuge. Supernatants were transferred, diluted with 40 ml of denaturation solution [10 mM Tris-HC1 (pH 7.5), SDS 0.5%], heated to 100°C for 10 rain, and cooled on ice. Triton X-100 was added to 1.0%, 100 vtl of rabbit anti-Spklp serum {Zheng et al. 1993) was added, and incubation was carried out at 4°C overnight with shaking. One hundred microliters of protein A-Sepharose (50% suspension in PBS without divalent cations) was added, and incubations were continued for 3 hr at 4°C with shaking. Beads were collected by centrifugation, transferred to 1.5-ml Eppendorf tubes, and washed three times in 0.5 ml of TG-VOa buffer. For Figure 4A , immunoprecipitation was carried out as described for the immunoprecipitation step in histone H1 kinase assays.
Imrnunobtotting
Samples were heated to 100°C for 5 rain in lx SDS sample buffer and fractionated on a 10% acrylamide-0.13% bisacrylamide gel. Proteins were transferred to nitrocellulose (Bio-Rad) in transfer buffer [72.25 grams of glycine, 15 grams of Tris base, 3.75 grams of SDS, 0.46 grams of sodium orthovanadate, 1 liter of methanol, H20 to 4 titers} at 4°C for 1 hr and 45 rain at 500 mA. Filters were then blocked in Blotto 15% Carnation Instant Milk in rinsing buffer (RB: 10 mM Tris-HC1 at pH 7.4, 0.9% NaC1, 0.01% sodium azide] overnight. Anti-Spklp antibody (1: 100) in Blotto was incubated with the filter for 2 hr at room temperature with shaking followed by two 10-rain washes in RB, one 10-min wash in RB containing 0.05% Triton X-100, and two 10-rain washes in RB. The filter was then incubated with 12~I-labeled protein A in RB/Blotto (30 ~tCi in 30 ml] for 30 inin at room temperature with shaking and washed five times as above. Filters were autoradiographed for 2 days using preflashed film at -70°C.
Histone H1 kinase assay
NY605 SPK1 cells were grown overnight in synthetic complete medium lacking uracil (SC-Ura), diluted, and grown to log phase in YPR. SPKI overexprcssion was induced by addition of galactose to a final concentration of 2% [wt/vol). Three hours later, 100 mN HU was added and cells were incubated at 30°C overnight. For HU-untreated cells, galactosc was added on day 2 to a fresh log-phase culture of NY605 SPK1 and NY605 spkI I cclls (grown as described as above). Cells were incubated for 3 hr and harvested in parallel with HU-treated cells. One hundred fifty milliliters of cells was collected for each sample. Cells wcrc lysed in 0.5 ml of glass bead disruption buffer by vortexing (as above], diluted with 0.5 ml of TG-VO4, and 80 ~1 of anti-Spklp serum was added. After incubation for 1.5 hr at 4°C, each lysate was divided into four equal parts. Fifty microliters of protein A-Sepharose (50% in TG-VO4 solution) was added to each portion followed by a further incubation with rotation for 30 min at 4°C. Sepharose beads were collected by centrifugation and were washed twice with TC~VO 4 solution and twice with kinase buffer [20 mM HEPES (pH 7.4), 10 mM MgC12, 10 mM MnC12]. Duplicate portions from each treatment were boiled immediately in 2x sample buffer for Western blot analysis. The other two were used for kinase assays. The washed complexes were incubated with 20 }xCi of [~/-;*aPIATP (Amersham; sp. act. >5000 Ci/mmole}, 2 b~g of histone H1 [Sigma), and 1 ~,M cold ATP in 25 ~l of kinase buffer for 7 min on ice. Reactions were terminated with 25 ~,1 of 2x sample buffer and boiling for 5 min. The eluted proteins were analyzed by SDS PAGE. The intensities of phosphorylated histone H1 (kinase assays) and Spklp (immunoblots) were detennined by PhosphorImager analysis.
